Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN Podcasts

Back to Item »

LINKING CHANGES IN GENE NETWORKS TO DISEASE

- Interview with Eric Schadt, Ph.D., Executive Scientific Director of Research Genetics for Rosetta Inpharmatics, Inc., a wholly-owned subsidiary of Merck & Co.



  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll